149 related articles for article (PubMed ID: 22282289)
1. The pharmaceutical industry has a contribution to make to evidence-based healthcare.
Sheehy K
N Z Med J; 2012 Jan; 125(1348):110-1. PubMed ID: 22282289
[No Abstract] [Full Text] [Related]
2. A policy of no pharmaceutical industry sponsorship: a case for health equity.
Pinhao Chao P
N Z Med J; 2011 Oct; 124(1344):115-6. PubMed ID: 22016176
[No Abstract] [Full Text] [Related]
3. New Zealand doctors and the pharmaceutical industry--time to cut the cord?
Menkes DB
N Z Med J; 2011 Aug; 124(1341):6-8. PubMed ID: 21959629
[No Abstract] [Full Text] [Related]
4. Banning pharmaceutical sponsorship: is ethical apartheid the right road ahead?
Gravatt L
N Z Med J; 2011 Nov; 124(1345):96-7. PubMed ID: 22072176
[No Abstract] [Full Text] [Related]
5. Psychological aspects of gifts from drug companies.
Goldrich MS
JAMA; 2003 Nov; 290(18):2405; author reply 2406-7. PubMed ID: 14612471
[No Abstract] [Full Text] [Related]
6. Conflicts of interest--an ever present challenge.
Kopp I
Dtsch Arztebl Int; 2013 Sep; 110(35-36):573-4. PubMed ID: 24078836
[No Abstract] [Full Text] [Related]
7. Relationships between medical students and drug companies in New Zealand.
Wyber R; Fancourt N; Stone B
N Z Med J; 2011 Aug; 124(1341):58-64. PubMed ID: 21959637
[TBL] [Abstract][Full Text] [Related]
8. Medicine and the pharmaceutical industry: a call to action.
Stiles MM; Barrett B
Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
[No Abstract] [Full Text] [Related]
9. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
10. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
Greenland P
Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
[No Abstract] [Full Text] [Related]
11. Thanks, but no thanks.
Bell H
Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
[No Abstract] [Full Text] [Related]
12. The baby with the bathwater.
Buyske J
Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
[No Abstract] [Full Text] [Related]
13. Medical students protest perks from drug companies.
Opar A
Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
[No Abstract] [Full Text] [Related]
14. The ethics of pharmaceutical industry relationships with medical students.
Rogers WA; Mansfield PR; Braunack-Mayer AJ; Jureidini JN
Med J Aust; 2004 Apr; 180(8):411-4. PubMed ID: 15089733
[TBL] [Abstract][Full Text] [Related]
15. The death of common sense.
Trachtman H
Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
[No Abstract] [Full Text] [Related]
16. Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals.
Lieb K; Koch C
Dtsch Arztebl Int; 2013 Sep; 110(35-36):584-90. PubMed ID: 24078838
[TBL] [Abstract][Full Text] [Related]
17. Drug representatives: giving you lunch or stealing your soul?
Higgins SP
Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
[TBL] [Abstract][Full Text] [Related]
18. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
Barnes RK
Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
[No Abstract] [Full Text] [Related]
19. [Is drug promotion ethical in Peru?].
Florián Castro R
Gac Sanit; 2016; 30(2):159. PubMed ID: 26680685
[No Abstract] [Full Text] [Related]
20. Unconscious conflict of interest: a Jewish perspective.
Gold A; Appelbaum PS
J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
